|
Atomistry » Bromine » PDB 3u2d-3wk9 » 3uli | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Bromine » PDB 3u2d-3wk9 » 3uli » |
Bromine in PDB 3uli: Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole DerivativeEnzymatic activity of Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative
All present enzymatic activity of Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative:
2.7.11.22; Protein crystallography data
The structure of Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative, PDB code: 3uli
was solved by
N.A.Larsen,
J.A.Tucker,
T.Wang,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Bromine Binding Sites:
The binding sites of Bromine atom in the Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative
(pdb code 3uli). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative, PDB code: 3uli: Bromine binding site 1 out of 1 in 3uliGo back to![]() ![]()
Bromine binding site 1 out
of 1 in the Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative
![]() Mono view ![]() Stereo pair view
Reference:
T.Wang,
M.A.Block,
S.Cowen,
A.M.Davies,
E.Devereaux,
L.Gingipalli,
J.Johannes,
N.A.Larsen,
Q.Su,
J.A.Tucker,
D.Whitston,
J.Wu,
H.J.Zhang,
M.Zinda,
C.Chuaqui.
Discovery of Azabenzimidazole Derivatives As Potent, Selective Inhibitors of TBK1/Ikk Epsilon Kinases. Bioorg.Med.Chem.Lett. V. 22 2063 2012.
Page generated: Wed Jul 10 20:29:38 2024
ISSN: ISSN 0960-894X PubMed: 22305584 DOI: 10.1016/J.BMCL.2012.01.018 |
Last articlesZn in 9MJ5Zn in 9HNW Zn in 9G0L Zn in 9FNE Zn in 9DZN Zn in 9E0I Zn in 9D32 Zn in 9DAK Zn in 8ZXC Zn in 8ZUF |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |